Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of approximately...
Vous n'êtes pas connecté
Pancreatic ductal adenocarcinoma (PDAC) is a deadly type of pancreatic cancer. It’s aggressive, meaning it grows fast and spreads quickly. Unfortunately, there are few effective treatments, and survival rates are low. Only about 8% of people diagnosed with this cancer live more than five years. Despite these grim statistics, scientists are constantly searching for better […]
Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of approximately...
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving...
Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, transforming screening...
Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial...
THURSDAY, Nov. 14, 2024 -- An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast...
FRIDAY, Nov. 15, 2024 -- Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of...
FRIDAY, Nov. 15, 2024 -- Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of...
A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or high-risk prostate cancer...
Cancer Research team based at the University of Glasgow will receive the funding over the next five years.
Cancer Research team based at the University of Glasgow will receive the funding over the next five years.